text: Clinical features and follow up of pediatric patients hospitalized for COVID 19 This report summarizes the clinical features and 1 month follow up observations for pediatric patients who were hospitalized with coronavirus disease 2019 COVID 19 in Wuhan Women and Childrens Hospital The 1 month follow up data included clinical manifestations and results from serum severe acute respiratory syndrome coronavirus 2 SARS CoV 2 IgG and IgM tests reverse transcription polymerase chain reaction RT PCR for SARS CoV 2 lung computed tomography CT scans and laboratory tests Between January 20 and March 15 2020 127 patients aged 0 15 years were hospitalized for COVID 19 treatment including 3 severe cases and 124 mild or moderate cases The main therapies included inhalation of aerosolized interferon α 122 127 and additional antiviral drugs 28 127 Among the 81 patients who had pneumonia at admission 35 with right lobe pneumonia had the longest hospital stay mean 14 5 7 days 17 with left lobe pneumonia had the highest creatine kinase 154 106 U L and creatine kinase myocardial band CK MB 43 48 U L levels and 29 with bilateral pneumonia had the highest white blood cell counts 8 3 4 10 sup 9 sup L Among the 46 patients who were successfully followed up 1 month after discharge two notable findings were right lobe pneumonia in 22 95 confidence interval CI 11 37 of patients and persistently elevated serum creatine kinase and CK MB levels The median duration of elevated CK MB was 45 days The mean concentrations of serum SARS CoV 2 IgG and IgM in 41 patients were 8 0 7 5 and 98 40 ng ml respectively At follow up four patients retested positive for SARS CoV 2 The involvement of different lung lobes in patients with COVID 19 was associated with variations in the persistence of pneumonia and elevation of CK MB levels and body temperature 